GE HealthCare Technologies Inc. (GEHC) fair value analysis
S&P 500 & Nasdaq · Updated 2026-09-07
GE HealthCare Technologies Inc. is a healthcare technology company that designs, manufactures, and sells medical imaging equipment, software, and services including ultrasound, computed tomography, magnetic resonance imaging, and X-ray systems, along with digital healthcare solutions. The company operates globally across multiple regions including North America, Europe, Asia Pacific, and other international markets, serving hospitals, diagnostic imaging centers, and healthcare providers worldwide.
Forward Fair Value verdict
UndervaluedBased on TickrTrends' weekly Forward Fair Value model, GEHC is trading at more than a 25% discount to estimated fair value.
GEHC currently ranks #31 of 113 Healthcare stocks by discount to Forward Fair Value. It has screened as Undervalued for 3 consecutive weekly runs.
- Last price
- $68.86
- Sector
- Healthcare
- 12-month range
- $61.03–$82.82
Derived indicators
Coarse bands from TickrTrends' weekly models; exact figures are part of the full report.
- Quality grade
- F
- Momentum grade
- A
- Leverage
- Moderate
- Margin trend
- Stable
- Revenue growth
- Modest
- RSI zone
- Neutral
- 50/200-day trend
- Mixed
- 52-week position
- The lower-middle quarter of its range
- DCF cross-check
- Overvalued
What our data shows for GEHC
- Our model validated 14 trailing price-to-earnings windows for GEHC, built from quarterly earnings records.
- Shares are trading in the middle of their 12-month price range of $61.03–$82.82.
- The 14-day relative strength index sits at a neutral 41.
- 4 of the last 12 weekly snapshots showed positive price momentum.
The exact numbers are one step away
- The precise Forward Fair Value dollar figure for GEHC
- Exact discount / premium to today's price
- The normalized historical P/E behind the estimate, and how many quarters support it
- Forward EPS input and fiscal-year basis
- Screeners and rankings across the full S&P 500 and Nasdaq universes
How Forward Fair Value works
TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.
What people are saying
Follow the GEHC conversation: Stocktwits · Reddit · X
TickrTrends weekly updates
- 2026-09-07 — No material change this week: the verdict, bands and grades all held steady.
- 2026-09-06 — No material change this week: the verdict, bands and grades all held steady.
- 2026-08-31 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.
Frequently asked questions
Is GEHC stock undervalued?
Based on TickrTrends' Forward Fair Value model (updated 2026-09-07), GEHC is trading at more than a 25% discount to estimated fair value and screens as undervalued. The exact fair value and discount are available to subscribers.
What is GEHC's TickrTrends verdict?
GEHC's current verdict is Undervalued, refreshed with every weekly Forward Fair Value run.
How does GEHC compare to other Healthcare stocks?
GEHC ranks #31 of 113 Healthcare stocks in TickrTrends' coverage when sorted by discount to Forward Fair Value.
Is GEHC overbought or oversold?
GEHC's 14-day RSI is in neutral territory - neither overbought nor oversold.
More in Healthcare
Head-to-head comparisons
GEHC vs AVAH · GEHC vs CI · GEHC vs HSTM · GEHC vs IDXX · GEHC vs INDV